Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era

Blood (2020) 136 (Supplement 1): 52–53.

https://doi.org/10.1182/blood-2020-141790

Published: 2020

Journal Articles

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

Blood (2020) 136 (Supplement 1): 19–21.

https://doi.org/10.1182/blood-2020-136828

Published: 2020

Journal Articles

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 5472.

https://doi.org/10.1182/blood-2019-126353

Published: 2019

Journal Articles

T Cell Immunity Toward Viral- and Tumor-Antigens Is Preserved in MDS Patients

Hussein Hamad, MD, Wingchi K Leung, MD, Spyridoula Vasileiou, PhD, Shivani Mukhi, Quillan Huang, MD, George Carrum, MD, Carlos A. Ramos, MD, Rammurti Kamble, MD, LaQuisa C. Hill, MD, Ann M. Leen, PhD, Premal Lulla, MBBS

Blood (2019) 134 (Supplement_1): 4225.

https://doi.org/10.1182/blood-2019-126792

Published: 2019

Journal Articles

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 3175.

https://doi.org/10.1182/blood-2019-126341

Published: 2019

Journal Articles

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

George Carrum, MD, Premal Lulla, MBBS, Ifigeneia Tzannou, MD, Ayumi Watanabe, Manik Kuvalekar, Mrinalini Bilgi, Rammurti Kamble, MD, Carlos A. Ramos, MD, Rayne Rouce, MD, Bambi J. Grilley, RPh, Adrian P. Gee, PhD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MDDSc, Cliona M. Rooney, PhD, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2018-99-113140

Published: 2018

Journal Articles

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Swati Naik, MBBS, Premal Lulla, MBBS, Ifigeneia Tzannou, MD, Robert A. Krance, MD, George Carrum, MD, Rammurti Kamble, MD, Carlos A. Ramos, MD, Catherine Robertson, Manik Kuvalekar, Ayumi Watanabe, Bambi J. Grilley, RPh, Juan F. Vera, MD, Helen E. Heslop, MDDSc, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 2693.

https://doi.org/10.1182/blood-2018-99-115465

Published: 2018

Journal Articles

Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma

Premal Lulla, MBBS, Ifigeneia Tzannou, MD, George Carrum, MD, Carlos A. Ramos, MD, Rammurti Kamble, MD, Mrinalini Bilgi, Shivani Mukhi, Betty Chung, DO,MPH,MA, Ayumi Watanabe, Manik Kuvalekar, Adrian P. Gee, PhD, Bambi J. Grilley, RPh, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MDDSc, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2018) 132 (Supplement 1): 1014.

https://doi.org/10.1182/blood-2018-99-113118

Published: 2018

Journal Articles

Successful Plerixafor-Mediated Mobilization, Apheresis, and Lentiviral Vector Transduction of Hematopoietic Stem Cells in Patients with Severe Sickle Cell Disease

John F Tisdale, MD, Francis J. Pierciey, Jr., Rammurti Kamble, MD, Julie Kanter, MD, Lakshmanan Krishnamurti, MD, Janet L. Kwiatkowski, MD, Alexis A Thompson, MD MPH, Ilya Shestopalov, PhD, Melissa Bonner, PhD, Marcelyne Joseney-Antoine, Mohammed Asmal, MD PhD, Mark C. Walters, MD

Blood (2017) 130 (Supplement 1): 990.

https://doi.org/10.1182/blood.V130.Suppl_1.990.990

Published: 2017

Journal Articles

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Julie Kanter, MD, Mark C. Walters, MD, Matthew Hsieh, MD, Lakshmanan Krishnamurti, MD, Janet L. Kwiatkowski, MD, Rammurti Kamble, MD, Christof von Kalle, MD, Marcelyne Joseney-Antoine, Francis J. Pierciey, Jr., Weiliang Shi, PhD, Mohammed Asmal, MD PhD, Alexis A Thompson, MD MPH, John F Tisdale, MD

Blood (2017) 130 (Supplement 1): 527.

https://doi.org/10.1182/blood.V130.Suppl_1.527.527

Published: 2017

Journal Articles

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Premal Lulla, MBBS, Swati Naik, MBBS, Ifigeneia Tzannou, MD, Carlos A. Ramos, MD, Rammurti Kamble, MD, Catherine Robertson, Ayumi Watanabe, Manik Kuvalekar, Bambi J. Grilley, RPh, George Carrum, MD, Helen E. Heslop, MDDSc, Juan F. Vera, MD, Ann M. Leen, PhD

Blood (2017) 130 (Supplement 1): 164.

https://doi.org/10.1182/blood.V130.Suppl_1.164.164

Published: 2017

Journal Articles

A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis

Anish S. Konde, MB BS, Charles Camposano, Mushtaq Farah, Puppala Mamta, Wong Solomon, George Carrum, McCarthy John, Kelty R. Baker, MD, Jerry Estep, Arvind Bhimraj, Rammurti Kamble, MD, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD, MB, BS

Blood (2013) 122 (21): 3603.

https://doi.org/10.1182/blood.V122.21.3603.3603

Published: 2013

Journal Articles

Infusion of CD19-Directed and Multivirus Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation for B Cell Malignancies,

Conrad Russell Y. Cruz, MD, Kenneth P. Micklethwaite, MD, PhD, Barbara Savoldo, MD, PhD, Stephanie Ku, BS, Robert A. Krance, MD, Oumar Diouf, BS, Rammurti Kamble, MD, A. John Barrett, MD, Elizabeth J. Shpall, MD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, Gianpietro Dotti, MD

Blood (2011) 118 (21): 4083.

https://doi.org/10.1182/blood.V118.21.4083.4083

Published: 2011

Journal Articles

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Rammurti Kamble, MD, George Carrum, MD, Lawrence Rice, MD, John J. McCarthy, MD, Kelty R. Baker, MD, Carlos A. Ramos, MD, Horacio Adrogue, MD, Jerry Estep, MD

Blood (2011) 118 (21): 4489.

https://doi.org/10.1182/blood.V118.21.4489.4489

Published: 2011

Journal Articles

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Timothy S. Fenske, MD, Parameswaran Hari, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Rammurti Kamble, MD, J. Douglas Rizzo, MD, MS, Koen van Besien, MD, Hillard M. Lazarus, MD, Julie M. Vose, MD

Blood (2007) 110 (11): 19.

https://doi.org/10.1182/blood.V110.11.19.19

Published: 2007

Journal Articles

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Kiarash Kojouri, MD, MPH, Christian El-Khoury, MD, Shubham Pant, MD, Nancy Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5204.

https://doi.org/10.1182/blood.V104.11.5204.5204

Published: 2004

Journal Articles

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Christian El-Khoury, MD, Kiarash Kojouri, MD, MPH, Shubham Pant, MD, Nancy Sylvester-Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5206.

https://doi.org/10.1182/blood.V104.11.5206.5206

Published: 2004

NARROW

Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

T Cell Immunity Toward Viral- and Tumor-Antigens Is Preserved in MDS Patients

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma

Successful Plerixafor-Mediated Mobilization, Apheresis, and Lentiviral Vector Transduction of Hematopoietic Stem Cells in Patients with Severe Sickle Cell Disease

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis

Infusion of CD19-Directed and Multivirus Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation for B Cell Malignancies,

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only